eGFR CKD-EPI
Selected indexed studies
- The CKD-EPI 2021 Equation and Other Creatinine-Based Race-Independent eGFR Equations in Chronic Kidney Disease Diagnosis and Staging. (J Appl Lab Med, 2023) [PMID:37534520]
- Cystatin C and eGFR(CKD-EPI-CysC): novel biomarkers for renal impairment diagnosis and two-year progression-free survival in multiple myeloma. (Scand J Clin Lab Invest, 2023) [PMID:38145311]
- Chronic Kidney Disease: Prevention, Diagnosis, and Treatment. (Am Fam Physician, 2023) [PMID:38215416]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- The CKD-EPI 2021 Equation and Other Creatinine-Based Race-Independent eGFR Equations in Chronic Kidney Disease Diagnosis and Staging. (2023) pubmed
- Cystatin C and eGFR(CKD-EPI-CysC): novel biomarkers for renal impairment diagnosis and two-year progression-free survival in multiple myeloma. (2023) pubmed
- Chronic Kidney Disease: Prevention, Diagnosis, and Treatment. (2023) pubmed
- Clinical Impact of the Refit CKD-EPI 2021 Creatinine-Based eGFR Equation. (2022) pubmed
- Systematic review of international studies evaluating MDRD and CKD-EPI estimated glomerular filtration rate (eGFR) equations in Black adults. (2022) pubmed
- Performance of the race-free CKD-EPI creatinine-based eGFR equation in a Danish cohort with measured GFR. (2023) pubmed
- Diagnostic Accuracy of Creatinine-Based Equations for eGFR Estimation in Pakistanis: Evaluation of the European Kidney Function Consortium Equation vs the CKD-EPI Pakistan Equation. (2024) pubmed
- Correlation of eGFR By MDRD and CKD-EPI Formula with Creatinine Clearance Estimation in CKD Patients and Healthy Subjects. (2021) pubmed
- CKD prevalence based on real-world data: continuous age-dependent lower reference limits of eGFR with CKD-EPI, FAS and EKFC algorithms. (2022) pubmed
- Effects of the 2021 CKD-EPI Creatinine eGFR Equation among a National US Veteran Cohort. (2022) pubmed